Bristol-Myers Squibb Company's Head of Corporate and Business Development, Tamar D. Howson, to Address the Pharmaceutical Strategic Alliances Conference on Sept. 27 in New York

Business Wire, Sept 19, 2005

NORWALK, Conn. -- Bristol-Myers Squibb Company's (NYSE:BMY) senior vice president, corporate and business development, will address the 2005 Pharmaceutical Strategic Alliances Conference, organizer Windhover Information, Inc. announced today.

Tamar D. Howson will join other industry leaders in a panel discussion on Sept. 27 at 2:30 p.m. to discuss co-promotion agreements and other partnerships between large, small and mid-sized companies.

Bristol-Myers Squibb has built five $1-billion-plus franchises with corporate partners in the past decade alone. The company currently has more than 170 collaborations with about 130 companies and research institutions around the world.

Such partnerships, in combination with internal research and development, play an important role in Bristol-Myers Squibb's strategy of serving specialists and high-value primary care physicians by focusing its product portfolio and pipeline on disease areas of significant unmet need, where innovative medicines can help patients with serious illnesses.

Before joining Bristol-Myers Squibb in 2001, Howson was an independent business consultant helping several biotechnology companies in the development of strategic and tactical partnering plans. From 1991 to 2000, Howson was senior vice president and director, Business Development, for SmithKline Beecham Corporation. She holds a B.Sc. in Chemical Engineering from Technion (Haifa, Israel), an M.S. in Chemical Engineering from City College of New York, and an M.B.A. in Finance, International Business and Marketing from Columbia University.

Registration information on the Pharmaceutical Strategic Alliances Conference, Sept. 25 through Sept. 27 in New York, is available at www.windhover.com/psa.>

COPYRIGHT 2005 Business Wire

COPYRIGHT 2008 Gale, Cengage Learning